CD24 and graft versus host disease: In recent years, MSCs have emerged as candidates for the treatment of many diseases, for example, graft versus host disease (GVHD)23, CD24, type 1 diabetes25, allergic skin inflammation26, experimental autoimmune encephalomyelitis27, contusive spinal cord injury28, and acute pancreatitis29.